Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. (ISPR) delivers innovative vaping solutions through its Aspire e-cigarettes and cannabis vaporization systems. This news hub provides investors and industry professionals with essential updates on technological advancements, regulatory developments, and strategic partnerships shaping the alternative consumption market.
Access real-time announcements including quarterly earnings reports, product launch details, and manufacturing innovations. Our curated collection features press releases about precision dosing breakthroughs, ODM collaborations with global brands, and expansions into new international markets.
Stay informed about ISPR's progress in cannabis vaporization technology, patent filings, and compliance initiatives. The archive serves as a strategic resource for analyzing market trends and corporate milestones in the evolving vaping sector.
Bookmark this page for direct access to verified corporate communications. Combine regular monitoring with fundamental analysis tools to track ISPR's position in the competitive landscape of reduced-risk nicotine and cannabis delivery systems.
Ispire Technology Inc. (NASDAQ: ISPR) has launched VLT, a new reloadable pod system for vaping that aims to revolutionize the 510-thread experience. The system features a proprietary reload mechanism that promotes sustainability by reducing electronic waste through reusable batteries and pods. VLT's design preserves terpenes, extends product shelf life, and offers cost efficiency for manufacturers through the Ispire ONE™ filling machine. The company commits to donating a portion of proceeds to organizations fighting non-recyclable waste, making it a plastic-neutral product. The system is available in various pod sizes and colors, catering to THC, CBD, and alternative cannabinoid users.
Ispire Technology (NASDAQ: ISPR) and IKE Tech announced a successful pre-PMTA meeting with FDA's Center for Tobacco Products for their innovative Age Verification technology for electronic nicotine delivery systems (ENDS). The technology aims to prevent youth access while expanding adult market access to flavored PMTA-authorized products.
IKE Tech will submit a component PMTA, which if authorized, would allow ENDS manufacturers to incorporate their blockchain-based age-gating solution. The FDA indicated potential priority review consideration and acceptance of a component PMTA. The company plans to complete required studies in Q1 2025.
Ispire Technology (NASDAQ: ISPR) reported its fiscal Q1 2025 results, ending September 30, 2024.
Revenue was $39.3 million, down from $42.9 million in Q1 2024, an 8.2% decrease.
Gross profit increased 13.2% to $7.7 million, with margins rising from 16.0% to 19.5%.
Total operating expenses rose 67.0% to $12.9 million, attributed to increased marketing, stock-based compensation, and bad debt expenses.
Net loss widened to ($5.6) million or ($0.10) per share, compared to ($1.3) million or ($0.02) per share in Q1 2024.
The company expanded its global reach through a 5-year master distributor agreement with ANDS for MENA and global duty-free markets.
As of September 30, 2024, Ispire had $37.7 million in cash and working capital of $16.6 million.
Ispire Technology (NASDAQ: ISPR), a vaping technology and precision dosing company, has scheduled its fiscal first quarter 2025 earnings conference call for Tuesday, November 12, 2024, at 8:00am ET. The call will discuss financial results for the quarter ended September 30, 2024. Participants can join via phone using US number 866-250-8117 or international number +1 412-317-6011. The call will be broadcast live online, with playback available from 11:00 am ET on November 12 through November 26, 2024, using passcode 10193803.
Ispire Technology (NASDAQ: ISPR) has issued a correction to its previously announced fiscal first quarter 2025 earnings conference call details. The call will take place on Monday, November 11, 2024, at 8:00am ET, not Tuesday as initially stated. The correct dial-in numbers are United States 844-826-3033 or International +1 412-317-5185.
The call will discuss financial results for the quarter ended September 30, 2024. A live webcast will be available at the company's designated link, with access recommended 15 minutes before the call. A replay will be accessible from 11:00 am ET on November 11 through November 25, 2024, using passcode 10193803.
Ispire Technology Inc. (NASDAQ: ISPR), a company focused on vaping technology and precision dosing, announced its participation in MJ Unpacked 2024, a major cannabis industry event. Luna Stower, Head of Impact at Ispire, will participate as a panelist in the 'Impact of Women in Cannabis' discussion. The panel, moderated by Amy Larson from Rx Green Technologies, will explore women's leadership challenges and contributions in the cannabis industry. The event is scheduled for November 5, 2024, from 1:30 PM to 2:10 PM PT in the Grand Ballroom ABC.
Ispire Technology Inc. (NASDAQ: ISPR) has entered a five-year master distributor agreement with ANDS, a Dubai-based distributor, to expand its global reach. This partnership will bring Ispire's Hidden Hills Club nicotine portfolio to the Middle East, North Africa (MENA) region, and Global Duty-Free markets.
The collaboration covers 20+ MENA markets and provides access to more than 45 airports, cruise ships, airlines, and diplomatic facilities through ANDS' partnerships with major duty-free operators. This strategic move aims to meet the growing demand for harm-reduced alternatives to combustible cigarettes in one of the world's fastest-growing regions for alternative nicotine products.
The partnership leverages ANDS' expertise in regulatory, legal, compliance, brand building, sales, and distribution, along with local market insights, to position Ispire's products effectively in these new markets.
Ispire Technology Inc. (NASDAQ: ISPR) is set to unveil its revolutionary I-80 vapor device filling machine at the Benzinga Cannabis Capital Conference in Chicago on October 8-9. The I-80 promises to transform cannabis production efficiency with its ability to produce 4,000 fully filled and sealed vapor devices per hour, which is 10 times faster than traditional manual methods and twice as quick as current automated systems.
Key features of the I-80 include:
- Cost savings of $1,000 for every 10,000 units produced
- Elimination of separate capping process with Ispire's self-sealing devices
- Up to 1,000% boost in operational efficiency compared to manual methods
- Estimated 100% improvement over other automated systems
The I-80 is expected to attract significant interest from multi-state operators (MSOs), single-state operators (SSOs), and investors due to its potential to dramatically reduce costs and enhance productivity in the cannabis industry.
Ispire Technology Inc. (NASDAQ: ISPR), a vaping technology and precision dosing innovator, has announced its participation in four major industry events in October 2024:
1. Benzinga Cannabis Capital Conference in Chicago, IL (Oct 8-9)
2. THC Expo in Santiago, Chile (Oct 18-20)
3. The Vaper Expo UK in Birmingham, UK (Oct 25-27)
4. Earthstar Festival in Joshua Tree, California (Oct 25-27)
Company representatives will participate in panel discussions and presentations on topics including vape innovation, the global cannabis industry, and cannabis as medicine. Interested parties can schedule meetings with Ispire's leadership at these events.
Ispire Technology Inc. (NASDAQ: ISPR) reported financial results for fiscal year 2024, ending June 30, 2024. Revenue increased 31.4% to $151.9 million, while gross profit rose 43.3% to $29.8 million. The company's gross margin improved to 19.6% from 18.0% in the previous year. However, Ispire reported a net loss of $14.8 million, compared to a $6.0 million loss in fiscal 2023.
Key highlights include:
- Submission of PMTA application for re-entry into US ENDS market
- Opening of a new 31,000 sq. ft. facility in Malaysia
- Successful closure of a $12.3 million public offering
- Strategic partnerships with industry leaders
- Expansion in international nicotine and cannabis sectors
Despite challenges in the US cannabis industry, Ispire remains confident in its growth trajectory, focusing on quality investments and operational efficiency.